[Nesocytotropic effect in vitro. (Pancreatic islet cell lesions in the isolated organ)].
D000496:Alloxan / Q000633:toxicity*; D006801:Humans; D007004:Hypoglycemic Agents / Q000633:toxicity*; D066298:In Vitro Techniques; D062312:Islands; D007515:Islets of Langerhans / Q000494:pharmacology*; D046790:Pancreas, Exocrine; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000633:toxicity*; D014044:Tolbutamide / Q000633:toxicity*
D007004:Hypoglycemic Agents; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D000496:Alloxan; D014044:Tolbutamide
ALLOXAN/toxicology; ANTIDIABETICS/toxicology; ISLANDS OF LANGERHANS/pharmacology; SULFONAMIDES/toxicology; TOLBUTAMIDE/toxicology